Four innovations debut at ESHRE 2026
At this year's European Society of Human Reproduction and Embryology (ESHRE) Congress in London, we celebrated a major milestone by unveiling four groundbreaking innovations for IVF and andrology laboratories. This was the largest Human ART product launch in our company's 56-year history.
We presented these new technologies for the first time at the Minitube Human ART Pre-ESHRE Innovation Workshop. There, attendees received an exclusive preview and had the opportunity to discuss the latest developments with our team before the innovations were showcased throughout the congress.
These solutions were developed over the course of more than three years through close collaboration between our engineering, production, quality, marketing, sales, and service teams. They are designed to enhance quality, laboratory safety, and workflow efficiency in assisted reproduction.
The innovations introduced at ESHRE 2026 include:
These products are currently undergoing Medical Device Regulation (MDR) approval and are not yet commercially available.
Instead of waiting for the commercial launch, we decided to present these products early to gather valuable feedback from embryologists, andrologists, and IVF professionals. ESHRE, the world's leading congress in reproductive medicine, provides an ideal opportunity to test new technologies in real-world conditions and ensure they meet the highest standards of precision, reliability, and usability.
The response from customers, distribution partners, and industry experts throughout the Innovation Workshop and the congress was overwhelmingly positive. Our new technologies generated strong interest and valuable discussions that will continue to support the final stages of product development.
We thank everyone who attended the Minitube Human ART Innovation Workshop, visited our booth, and shared insights at ESHRE 2026. We look forward to bringing our innovations to laboratories worldwide and continuing the conversation with the global ART community at ESHRE 2027 in Stockholm.
* The products/features mentioned may not be commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed.
We presented these new technologies for the first time at the Minitube Human ART Pre-ESHRE Innovation Workshop. There, attendees received an exclusive preview and had the opportunity to discuss the latest developments with our team before the innovations were showcased throughout the congress.
These solutions were developed over the course of more than three years through close collaboration between our engineering, production, quality, marketing, sales, and service teams. They are designed to enhance quality, laboratory safety, and workflow efficiency in assisted reproduction.
The innovations introduced at ESHRE 2026 include:
- AndroVision® med*: a CASA system for advanced sperm analysis
- MiniQube: an innovative digital microscope and Red Dot Design Award winner
- sFlow*: a next-generation sperm selection solution
- AndroStation: a dedicated workstation for sFlow
These products are currently undergoing Medical Device Regulation (MDR) approval and are not yet commercially available.
Instead of waiting for the commercial launch, we decided to present these products early to gather valuable feedback from embryologists, andrologists, and IVF professionals. ESHRE, the world's leading congress in reproductive medicine, provides an ideal opportunity to test new technologies in real-world conditions and ensure they meet the highest standards of precision, reliability, and usability.
The response from customers, distribution partners, and industry experts throughout the Innovation Workshop and the congress was overwhelmingly positive. Our new technologies generated strong interest and valuable discussions that will continue to support the final stages of product development.
We thank everyone who attended the Minitube Human ART Innovation Workshop, visited our booth, and shared insights at ESHRE 2026. We look forward to bringing our innovations to laboratories worldwide and continuing the conversation with the global ART community at ESHRE 2027 in Stockholm.
* The products/features mentioned may not be commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed.
